MAPT and Alzheimer disease: It is widely accepted that the gradual enrichment of Amyloid-β (Aβ) peptide as well as abnormal or hyperphosphorylated Tau are strongly correlated with AD pathogenesis (Khayat et al., 2021; Wegmann et al., 2021; Zhang et al., 2021).